| Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells M Lin, JF Chen, YT Lu, Y Zhang, J Song, S Hou, Z Ke, HR Tseng Accounts of chemical research 47 (10), 2941-2950, 2014 | 239 | 2014 |
| High‐purity prostate circulating tumor cell isolation by a polymer nanofiber‐embedded microchip for whole exome sequencing L Zhao, YT Lu, F Li, K Wu, S Hou, J Yu, Q Shen, D Wu, M Song, ... Advanced materials 25 (21), 2897-2902, 2013 | 175 | 2013 |
| NanoVelcro Chip for CTC enumeration in prostate cancer patients YT Lu, L Zhao, Q Shen, MA Garcia, D Wu, S Hou, M Song, X Xu, ... Methods 64 (2), 144-152, 2013 | 157 | 2013 |
| miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer S Josson, M Gururajan, P Hu, C Shao, GCY Chu, HE Zhau, C Liu, K Lao, ... Clinical cancer research 20 (17), 4636-4646, 2014 | 147 | 2014 |
| Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases JF Chen, H Ho, J Lichterman, YT Lu, Y Zhang, MA Garcia, SF Chen, ... Cancer 121 (18), 3240-3251, 2015 | 118 | 2015 |
| A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens J Sun, MD Masterman-Smith, NA Graham, J Jiao, J Mottahedeh, DR Laks, ... Cancer research 70 (15), 6128-6138, 2010 | 116 | 2010 |
| miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer M Gururajan, S Josson, GCY Chu, CL Lu, YT Lu, CL Haga, HE Zhau, ... Clinical Cancer Research 20 (24), 6559-6569, 2014 | 111 | 2014 |
| A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer R Jiang, YT Lu, H Ho, B Li, JF Chen, M Lin, F Li, K Wu, H Wu, ... Oncotarget 6 (42), 44781, 2015 | 110 | 2015 |
| NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells YJ Jan, JF Chen, Y Zhu, YT Lu, SH Chen, H Chung, M Smalley, ... Advanced drug delivery reviews 125, 78-93, 2018 | 107 | 2018 |
| Clinical applications of NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells JF Chen, Y Zhu, YT Lu, E Hodara, S Hou, VG Agopian, JS Tomlinson, ... Theranostics 6 (9), 1425, 2016 | 62 | 2016 |
| Current status of liquid biopsies for the detection and management of prostate cancer YT Lu, K Delijani, A Mecum, A Goldkorn Cancer management and research, 5271-5291, 2019 | 59 | 2019 |
| Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells Q Li, L Yin, LW Jones, GCY Chu, JBY Wu, JM Huang, Q Li, S You, J Kim, ... Oncotarget 7 (51), 84645, 2016 | 37 | 2016 |
| A circulating tumor cell-RNA assay for assessment of androgen receptor signaling inhibitor sensitivity in metastatic castration-resistant prostate cancer YJ Jan, J Yoon, JF Chen, PC Teng, N Yao, S Cheng, A Lozano, GCY Chu, ... Theranostics 9 (10), 2812, 2019 | 23 | 2019 |
| Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype T Xu, HT Li, J Wei, M Li, TC Hsieh, YT Lu, R Lakshminarasimhan, R Xu, ... International journal of cancer 146 (11), 3065-3076, 2020 | 16 | 2020 |
| Circulating tumor cells in prostate cancer: beyond enumeration JF Chen, YT Lu, S Cheng, HR Tseng, RA Figlin, EM Posadas Clin Adv Hematol Oncol 15, 63-73, 2017 | 12 | 2017 |
| Cell-free DNA methylation as a predictive biomarker of response to neoadjuvant chemotherapy for patients with muscle-invasive bladder cancer in SWOG S1314 YT Lu, M Plets, G Morrison, AT Cunha, SY Cen, SK Rhie, KD Siegmund, ... European Urology Oncology 6 (5), 516-524, 2023 | 11 | 2023 |
| Non-invasive profiling of advanced prostate cancer via multi-parametric liquid biopsy and radiomic analysis G Morrison, J Buckley, D Ostrow, B Varghese, SY Cen, J Werbin, ... International Journal of Molecular Sciences 23 (5), 2571, 2022 | 8 | 2022 |
| Bladder cancer cells shift rapidly and spontaneously to cisplatin-resistant oxidative phosphorylation that is trackable in real time T Xu, JA Junge, A Delfarah, YT Lu, C Arnesano, M Iqbal, K Delijani, ... Scientific Reports 12 (1), 5518, 2022 | 7 | 2022 |
| FOXC1 binds enhancers and promotes cisplatin resistance in bladder cancer YT Lu, T Xu, M Iqbal, TC Hsieh, Z Luo, G Liang, PJ Farnham, SK Rhie, ... Cancers 14 (7), 1717, 2022 | 7 | 2022 |
| Cell-free DNA methylation as a predictive biomarker of response to neoadjuvant chemotherapy for patients with muscle-invasive bladder cancer in SWOG S1314. YT Lu, M Plets, G Morrison, AT Cunha, SY Cen, SK Rhie, K Siegmund, ... Journal of Clinical Oncology 40 (16_suppl), 4506-4506, 2022 | 5 | 2022 |
Edwin PosadasMedical Director, Urologic Oncology Program; Director, Translational Oncology Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center在 csmc.edu 的電子郵件地址已通過驗證
